Drug effects on cardiac inotropism.
D000199:Actins / Q000502:physiology; D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000502:physiology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002301:Cardiac Glycosides / Q000494:pharmacology; D004285:Dogs; D006321:Heart / Q000502:physiology*; D009119:Muscle Contraction / Q000187:drug effects*; D009124:Muscle Proteins / Q000502:physiology; D009132:Muscles / Q000502:physiology; D009210:Myofibrils / Q000502:physiology; D009218:Myosins / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D009994:Osmolar Concentration; D010042:Ouabain / Q000494:pharmacology; D010600:Pharmacology; D014970:Xanthines / Q000494:pharmacology
D000199:Actins; D000319:Adrenergic beta-Antagonists; D001463:Barbiturates; D002301:Cardiac Glycosides; D009124:Muscle Proteins; D014970:Xanthines; D010042:Ouabain; D000255:Adenosine Triphosphate; D009218:Myosins; D002118:Calcium; D009638:Norepinephrine